{HEAD ~ The compounds} of formula I and {TAIL ~ the pharmaceutically acceptable salts} thereof inhibit the effects of VEGF, a property of value in the treatment of a number of diseases states including cancer and rheumatoid arthritis 
of
{ HEAD ~ The compounds } of formula I and { TAIL ~ the pharmaceutically acceptable salts } thereof inhibit the effects of VEGF , a property of value in the treatment of a number of diseases states including cancer and rheumatoid arthritis
HEAD HEAD HEAD HEAD HEAD HEAD REL OTH OTH OTH TAIL TAIL TAIL TAIL TAIL TAIL TAIL TAIL OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH